Fundraising FoxCelsius Therapeutics
acquired by AbbVieCambridge, US · Founded 2017 · Delaware corporation · 7 known investors
Find your way into Celsius Therapeutics
Sign up to see every warm intro you have to Celsius Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Celsius Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Combines single-cell RNA analysis technology from the Broad Institute with AI/ML models and large-scale clinical sample collection for novel drug discovery and precision medicine. Acquired by AbbVie Inc. in June 2024.
Founders & leadership
Investors · 7
How we know: Catalio Capital Management, LP's portfolio page · Not right? Tell us
How we know: Fast Track Initiative's portfolio page · Not right? Tell us
How we know: GV (Google Ventures)'s portfolio page · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · open dataset · 5k.vc investor directory · Not right? Tell us
Funding
SEC filings, press & company announcements$48M disclosed across 1 of 2 rounds · 2018–2022
- Undisclosed amountSeries BMar 2022Source ↗
▶$48MraisedOct 2019 · 6 investors · Other Health CareRule 506(b)
- Michael BorettiExecutive Officer
- Tariq KassumExecutive Officer, Director
- Christoph LengauerExecutive Officer, Director
- Offering amount
- $65M
- Amount sold
- $48M
- First sale
- May 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Celsius Therapeutics went on to found or lead other companies.
Frequently asked questions
- What does Celsius Therapeutics do?
- Combines single-cell RNA analysis technology from the Broad Institute with AI/ML models and large-scale clinical sample collection for novel drug discovery and precision medicine. Acquired by AbbVie Inc. in June 2024.
- Who are Celsius Therapeutics's investors?
- Celsius Therapeutics's investors include Catalio Capital Management, LP, Fast Track Initiative, GV (Google Ventures), Alexandria, Amplitude Venture Capital, Casdin Capital, Third Rock Ventures.
- How much funding has Celsius Therapeutics raised?
- Celsius Therapeutics has disclosed $48M raised across 1 of its 2 known rounds.
- Who acquired Celsius Therapeutics?
- Celsius Therapeutics was acquired by AbbVie.
- Where is Celsius Therapeutics headquartered?
- Celsius Therapeutics is headquartered in Cambridge, US.